Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
January 1, 1989
[Assay of the laminin P1 using a radioimmunologic technic: applications in oncology]
H Larbre, L Loemba, G Deltour
Clinical Biochemistry
|
October 1, 1991
Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma
B Desoize, S Amico, H Larbre, et al.
Bulletin Du Cancer
|
January 1, 1990
[Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]
B Desoize, C Pourny, S Amico, et al.
Clinical Nuclear Medicine
|
September 1, 1991
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma
S Amico, J C Liehn, B Desoize, et al.
Anticancer Research
|
July 1, 1990
CA-50 and CA-19.9 as tumour markers: which is preferable?
F Maréchal, G Berthiot, M G Legrand, et al.
La Revue De Medecine Interne
|
July 22, 2006
[How to interprete hypercalcitoninemia?]
N Levy-Bohbot, M Patey, H Larbre, et al.
Revue Des Maladies Respiratoires
|
January 1, 1994
[Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]
A Prévost, F Passemard, D Perdu, et al.
Diabetes & Metabolism
|
August 5, 1998
Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus
E Bertin, N Rich, N Schneider, et al.
Annales D'Endocrinologie
|
November 21, 2000
[Positive antithyroglobulin antibodies in patients with differentiated thyroid carcinoma. What significance?]
H Larbre, C Schvartz, N Schneider, et al.
Clinical Biochemistry
|
June 1, 1996
Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region
C Delvincourt, M Patey, J B Flament, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
January 1, 1989
[Assay of the laminin P1 using a radioimmunologic technic: applications in oncology]
H Larbre, L Loemba, G Deltour
Clinical Biochemistry
|
October 1, 1991
Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma
B Desoize, S Amico, H Larbre, et al.
Bulletin Du Cancer
|
January 1, 1990
[Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]
B Desoize, C Pourny, S Amico, et al.
Clinical Nuclear Medicine
|
September 1, 1991
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma
S Amico, J C Liehn, B Desoize, et al.
Anticancer Research
|
July 1, 1990
CA-50 and CA-19.9 as tumour markers: which is preferable?
F Maréchal, G Berthiot, M G Legrand, et al.
La Revue De Medecine Interne
|
July 22, 2006
[How to interprete hypercalcitoninemia?]
N Levy-Bohbot, M Patey, H Larbre, et al.
Revue Des Maladies Respiratoires
|
January 1, 1994
[Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]
A Prévost, F Passemard, D Perdu, et al.
Diabetes & Metabolism
|
August 5, 1998
Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus
E Bertin, N Rich, N Schneider, et al.
Annales D'Endocrinologie
|
November 21, 2000
[Positive antithyroglobulin antibodies in patients with differentiated thyroid carcinoma. What significance?]
H Larbre, C Schvartz, N Schneider, et al.
Clinical Biochemistry
|
June 1, 1996
Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region
C Delvincourt, M Patey, J B Flament, et al.
Page
of 2